LIGAND PHARMACEUTICALS INCORPORATED Operating Leases, Rent Expense, Net
LIGAND PHARMACEUTICALS INCORPORATED (LGNYZ) reported Operating Leases, Rent Expense, Net of $1.70 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseNet · last filed 2017-02-28
- LIGAND PHARMACEUTICALS INCORPORATED operating leases, rent expense, net for the quarter ending 2016-06-30 was $600.00K, a 33.33% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED operating leases, rent expense, net for the quarter ending 2016-03-31 was $600.00K, a 33.33% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED operating leases, rent expense, net for the quarter ending 2015-12-31 was $600.00K, a 33.33% decline year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED operating leases, rent expense, net for the quarter ending 2015-09-30 was $800.00K, a 0.00% change year-over-year.
- LIGAND PHARMACEUTICALS INCORPORATED operating leases, rent expense, net for fiscal 2016 was $1.70M, a 48.48% decline from fiscal 2015.
- LIGAND PHARMACEUTICALS INCORPORATED operating leases, rent expense, net for fiscal 2015 was $3.30M, a 5.71% decline from fiscal 2014.
- LIGAND PHARMACEUTICALS INCORPORATED operating leases, rent expense, net for fiscal 2014 was $3.50M, a 5.41% decline from fiscal 2013.
- LIGAND PHARMACEUTICALS INCORPORATED operating leases, rent expense, net for fiscal 2013 was $3.70M, a 2.78% increase from fiscal 2012.
| Period end | Operating Leases, Rent Expense, Net 3 month | Operating Leases, Rent Expense, Net 6 month | Operating Leases, Rent Expense, Net 9 month | Operating Leases, Rent Expense, Net 12 month | Operating Leases, Rent Expense, Net 12 month as first filed |
|---|---|---|---|---|---|
| 2016-12-31 | $1.70M 10-K · filed 2017-02-28 | ||||
| 2016-06-30 | $600.00K 10-Q · filed 2016-11-14 | $1.20M 10-Q · filed 2016-11-14 | $1.80M derived: sum of 3 quarters · filed 2017-02-28 | $2.60M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2016-03-31 | $600.00K 10-Q · filed 2016-11-14 | $1.20M derived: sum of 2 quarters · filed 2017-02-28 | $2.00M derived: sum of 3 quarters · filed 2017-02-28 | $2.90M derived: sum of 4 quarters · filed 2017-02-28 | |
| 2015-12-31 | $600.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $1.40M derived: sum of 2 quarters · filed 2017-02-28 | $2.30M derived: sum of 3 quarters · filed 2017-02-28 | $3.30M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $800.00K 10-Q · filed 2015-11-09 | $1.70M derived: sum of 2 quarters · filed 2016-11-14 | $2.70M 10-Q · filed 2015-11-09 | $3.50M derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | $900.00K 10-Q · filed 2016-11-14 | $1.90M 10-Q · filed 2016-11-14 | $2.70M derived: sum of 3 quarters · filed 2016-11-14 | $3.50M derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-03-31 | $900.00K 10-Q · filed 2016-11-14 | $1.80M derived: sum of 2 quarters · filed 2016-11-14 | $2.60M derived: sum of 3 quarters · filed 2016-11-14 | $3.50M derived: sum of 4 quarters · filed 2016-11-14 | |
| 2014-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-14 | $1.70M derived: sum of 2 quarters · filed 2016-11-14 | $2.60M derived: sum of 3 quarters · filed 2016-11-14 | $3.50M 10-K · filed 2016-11-14 | $3.70M 10-K · filed 2014-12-01 |
| 2014-09-30 | $800.00K 10-Q · filed 2015-11-09 | $1.70M derived: sum of 2 quarters · filed 2015-11-09 | $2.60M 10-Q · filed 2015-11-09 | $3.50M derived: sum of 4 quarters · filed 2015-11-09 | |
| 2014-06-30 | $900.00K 10-Q · filed 2015-08-05 | $1.80M 10-Q · filed 2015-08-05 | $2.70M derived: sum of 3 quarters · filed 2015-08-05 | $3.60M derived: sum of 4 quarters · filed 2015-08-05 | |
| 2014-03-31 | $900.00K 10-Q · filed 2015-05-11 | $1.80M derived: sum of 2 quarters · filed 2015-05-11 | $2.70M derived: sum of 3 quarters · filed 2015-05-11 | $3.60M derived: sum of 4 quarters · filed 2015-05-11 | |
| 2013-12-31 | $900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-23 | $1.80M derived: sum of 2 quarters · filed 2015-02-23 | $2.70M derived: sum of 3 quarters · filed 2015-02-23 | $3.70M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $900.00K 10-Q · filed 2014-10-31 | $1.80M derived: sum of 2 quarters · filed 2014-10-31 | $2.80M 10-Q · filed 2014-10-31 | $3.80M derived: sum of 4 quarters · filed 2014-12-12 | |
| 2013-06-30 | $900.00K 10-Q · filed 2014-08-05 | $1.90M 10-Q · filed 2014-08-05 | $2.90M derived: sum of 3 quarters · filed 2014-12-12 | $3.90M derived: sum of 4 quarters · filed 2014-12-12 | |
| 2013-03-31 | $1.00M 10-Q · filed 2014-05-07 | $2.00M derived: sum of 2 quarters · filed 2014-12-12 | $3.00M derived: sum of 3 quarters · filed 2014-12-12 | ||
| 2012-12-31 | $1.00M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-12-12 | $2.00M derived: sum of 2 quarters · filed 2014-12-12 | $3.60M 10-K/A · filed 2014-12-12 | ||
| 2012-09-30 | $1.00M 10-Q · filed 2013-11-08 | $2.60M 10-Q · filed 2013-11-08 |